Amcor (ASX:AMC) share price lifts on FY21 earnings

Shares in the food packaging giant are on the move today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Amcor CDI (ASX: AMC) share price has stepped 3% into the green as the global packaging company reported its FY21 earnings.

Let's investigate further.

A happy woman in a hard hat gives two thumbs up, standing in a packing warehouse.

Image source: Getty Images

Amcor share price jumps on strong net income and free cash flow growth

The Amcor share price is on the move after these investment highlights from its FY21 earnings report:

  • Net income of $939 million (up 53%) with earnings per share (EPS) of 60.2 cents (up 58%)
  • Adjusted free cash flow of $1.1 billion, at upper end of guidance range
  • Bemis integration completed – approximately $75 million of cost synergies in FY21; total expected to exceed $180 million target by at least 10%
  • Annual dividend increased to 47 cents per share, including a final 11.75 cents per share declared in its report
  • $350 million shares repurchased in FY21

What happened in FY21 for Amcor?

Amcor grew net sales by 2% year on year to $12.8 billion, underscored by strong sales momentum and the pass-through of "higher raw material input costs".

The company also outlined the "cost synergies" obtained via the Bemis Company acquisition in June 2019.

In consequence of its execution strategy from the acquisition, Amcor has "delivered approximately $75 million of incremental cost synergies" during FY21.

The total "cumulative cost synergies" from the acquisition now totals around $155 million, as per the release.

As a result, Amcor managed to deliver "record full-year earnings" in FY21. Moreover, net income grew by 53% year over year, which came through to free cash flow of $1.1 billion.

Given its "significant and growing free cash flow," Amcor will return cash to its shareholders by way of dividend, declaring an 11.75 cents-per-share payment in its FY21 earnings.

This brings the FY21 dividend to US47 cents per share, payable on 28 September.

Furthermore, $350 million was used to repurchase its own shares in FY21. This reduces the total number of shares outstanding by approximately 2%.

Amcor estimates it will allocate approximately $400 million "of cash towards share repurchases" in FY22.

What did management say?

Amcor CEO Ron Delia said:

Amcor delivered record full year earnings in 2021, as our teams successfully executed against our strategy, delivered growth and increased EBIT margins while managing exceptionally well through steep raw material cost increases and supply constraints.

On cashflow, Delia added:

The strong cash flow also enabled significant cash returns to shareholders through a higher annual dividend and the repurchase of shares. Across the business we ended the year with good momentum and we expect another strong year in fiscal 2022.

Finally, regarding the Bemis acquisition:

In the two years following our transformational acquisition of Bemis, we have strengthened our financial profile and consistently built earnings momentum. The integration is essentially complete and we will exceed our original $180 million cost synergy target by at least 10% and Free Cash Flow for fiscal 2022 is expected to be almost double pre acquisition levels.

What's next for Amcor shares?

Management anticipates a strong year underlined by sales momentum, but acknowledges COVID-19 "creates a higher degree of uncertainty" in forecasts.

Amcor estimates adjusted EPS growth in the ranges of 7%–11%. This coupled with free cash flow generation of $1.1 billion to $1.2 billion. This calls for 79 to 81 cents per share, as per the company.

Moreover, as mentioned, it will allocate around $400 million to share repurchases in FY22.

Amcor shares have lagged the S&P/ASX 200 Index (ASX: XJO) this year, posting a return of 11.6%. This compares to the ASX 200's gain of 14%.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Amcor Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »